Company Monitoring Page for Novo-Nordisk

latest headlines for company on cafepharma

With Obesity on the Continued Rise in the U.S., More Anti-Obesity Drugs Are Heading for the Market
BioSpace
Wed, 02/13/19 - 10:06 am
Tags:
obesity, Sanofi, Novo Nordisk, AstraZeneca
An oral insulin delivery system inspired by tortoises
Fierce Biotech
Thu, 02/7/19 - 11:19 pm
Tags:
diabetes, insulin, drug delivery, MIT, Brigham and Women's, Novo Nordisk, OI388GT
Mark Your Calendar For These February PDUFA Dates
Yahoo/Benzinga
Sat, 02/2/19 - 12:31 pm
Tags:
FDA, DWP-450, Evolus, MOTIF BIO PLC/S ADR, Iclaprim, Bausch Health, Duobrii, Merck, Keytruda, Incyte, Novartis, ruxolitinib, Novo Nordisk, N8-GP
Q4 Biopharma Themes: Strong 2018, Weaker 2019 Earnings Projections, Concerns over Drug Pricing
BioSpace
Fri, 02/1/19 - 11:27 am
Tags:
earnings, Pfizer, Amgen, AbbVie, JNJ, Merck, Novo Nordisk, Takeda
Novo bets on swift FDA review for oral diabetes drug semaglutide
Endpoints
Fri, 02/1/19 - 09:50 am
Tags:
Novo Nordisk, earnings, semaglutide, FDA
On heels of drug pricing hearings, Democratic lawmakers kick off insulin probe
Fierce Pharma
Thu, 01/31/19 - 11:53 pm
Tags:
Sanofi, Novo Nordisk, diabetes, insulin, drug pricing
Novo Holdings' antibiotic resistance fund backs 3 biotechs
Fierce Biotech
Mon, 01/21/19 - 12:32 pm
Tags:
Novo Nordisk, Novo Holdings, antibiotic resistance, Minervax, Procarta Biosystems, Entasis Therapeutics
Novo Nordisk’s first diabetes innovation challenge winners head to the lab
Fierce Pharma
Sat, 01/5/19 - 01:32 pm
Tags:
Novo Nordisk, diabetes, innovation
3 Biotechs With Potential Blockbusters Near the Finish Line
Motley Fool
Tue, 12/18/18 - 12:48 pm
Tags:
Vertex Pharmaceuticals, VX-659 + tezacaftor + ivacaftor, Celgene, JCAR017, Novo Nordisk, semaglutide
Novo bags €430M Staten buyout option to boost cardiovascular disease pipeline
Fierce Biotech
Mon, 12/17/18 - 09:12 am
Tags:
Novo Nordisk, Staten Biotechnology, M&A
Novo taps e-therapeutics for diabetes target discovery drive
Fierce Biotech
Tue, 12/11/18 - 10:21 am
Tags:
Novo Nordisk, e-therapeutics, R&D, drug development
Novo keeps adding capacity, and jobs, to its North Carolina drug plant
Fierce Pharma
Wed, 12/5/18 - 07:40 pm
Tags:
Novo Nordisk, drug manufacturing, diabetes, North Carolina
Novo Nordisk’s diabetes pill clears cardiac safety hurdle
Pharmaforum
Mon, 11/26/18 - 09:56 am
Tags:
Novo Nordisk, semaglutides, type 2 diabetes, clinical trials, cardiovascular outcomes
Novo Nordisk staff cull swells to 1,300
Pharmaforum
Fri, 11/2/18 - 11:28 am
Tags:
Novo Nordisk, layoffs, artificial intelligence
Weeks after launching Aeterna Zentaris castoff, Strongbridge turns around and sells rights to Novo Nordisk — at a premium
Endpoints
Wed, 10/31/18 - 11:47 am
Tags:
Strongbridge, Aeterna Zentaris, Macrilen, Novo Nordisk, adult growth hormone deficiency
Digital diabetes mavens Novo Nordisk and Sanofi top new patient experience ranking
Fierce Pharma
Mon, 10/29/18 - 11:45 am
Tags:
patients, patient experience data, Sanofi, Novo Nordisk, type 2 diabetes
Minnesota takes aim at Sanofi, Novo, Lilly for insulin prices
Biopharma Dive
Thu, 10/18/18 - 12:12 am
Tags:
Minnesota, insulin, diabetes, PBMs, Sanofi, Novo Nordisk, Eli Lilly
Anthem, HealthCore and Novo Nordisk for Partnership to Study Benefits New Type 2 Diabetes Drug Vs Other Available Drugs
CP Wire
Wed, 10/17/18 - 10:26 am
Tags:
Anthem, Novo Nordisk, Ozempic, type 2 diabetes
Wed, 10/17/18 - 10:23 am
Tags:
Anthem, Novo Nordisk, Ozempic, type 2 diabetes
Novo Nordisk picks AstraZeneca executive to head biopharma business
Yahoo/Reuters
Mon, 10/15/18 - 10:38 am
Tags:
Novo Nordisk, AstraZeneca, Ludovic Helfgott

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.